BPC-157: nitric oxide, angiogenesis, tendon-fibroblast outgrowth BPC-157 (Body Protection Compound 157) is a 15-amino-acid pentadecapeptide first characterized by the Sikiric group at the University of Zagreb beginning in the early 1990s
But by keeping up with coding changes and payer policy updates, this process can be much easier than breaking the news to a patient that they need the treatment
They will not use these products for human or animal consumption
However, it's essential to consult a veterinarian before administering BPC 157 to ensure it is appropriate for your dog's specific health needs and conditions
10.1111/and.14062 53 World Anti-Doping Agency (2022)
Without addressing gut health, stress, or dietary triggers , flare-ups can reappear, and joint damage may continue